Drug Trial Radar · NCT04716712
Infant Mortality Reduction by the Mass Administration of Azithromycin
Last checked: Nov 19, 2026Latest source record: Mar 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
694,400
Planned (sponsor's estimate)
Start
Oct 4, 2021
Primary completion
Jan 30, 2025
Study completion Jan 30, 2026
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Helen Keller International; Centre de Recherche en Sante de Nouna, Burkina Faso; Bill and Melinda Gates Foundation
- First posted
- Jan 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 month, up to 11 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This trial will investigate the supplementation of azithromycin distribution to the "Child Health Days" platform in Burkina Faso for child mortality reduction. This distribution will pair door-to-door administration of vitamin A and azithromycin or placebo with acute malnutrition screening among children 1-11 months old.
Conditions
- Child Mortality
Interventions
AzithromycinDrug
Azithromycin is a macrolide-type antibiotic that is used to treat various types of infections. Previous studies in Niger have demonstrated a nearly 18% reduction in all-cause child mortality following biannual mass administration to children 1-59 months.
PlaceboDrug
Matching identical placebo in packaging, appearance, and taste.
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortalityTime frame: 24 months following baseline
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California
Centre de Recherche en Sante de Nouna
Nouna, Burkina Faso
Helen Keller International
Ouagadougou, Burkina Faso
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.